Bambusa Therapeutics

Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.

Company Details

Founded: 2024
Employees: Between 10 - 50 employees
Raised: $105,000,000
Public: No
Acquired: No
CEO: Shanshan Xu
Founders: Helmut Jeggle
Shanshan Xu

Company Collections

These are collections Bambusa Therapeutics is a part of. Click on the collection name to view similar companies.

Bambusa Therapeutics' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Total Amount Raised: $105,000,000

Bambusa Therapeutics Funding Rounds

Series A
$90,000,000
Feb 13, 2025
Series A Investors
RA Capital Management
Janus Henderson Investors
Invus Group
ADAR1 Capital Management
Redmile Group
Seed
$15,000,000
Sep 8, 2024
Seed Investors
Bvf Partners
Dawn Biopharma
Salvia
INCE Capital

Funding info provided by Diffbot.

Bambusa Therapeutics Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Bambusa Therapeutics.